HAFN Stock Analysis: Hafnia | NYSE
Marine Shipping | NYSE, USA | Market Cap: 3.319m USD | 12M Return: 48.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.6M
EPS Trend: -89.2%
Qual. Beats: 1
Rev. Trend: -44.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hafnia Limited is a Singapore-based investment holding company that owns and operates a fleet of oil product tankers. The company is organized into four operating segments-Long Range II, Long Range I, Medium Range (MR), and Handy Size-covering a broad spectrum of vessel capacities used to transport clean and dirty refined oil products, vegetable oils, and easy chemicals. Its customer base spans national and international oil companies, chemical firms, and trading and utility companies. Beyond ship owning, Hafnia is involved in chartering and the provision of maritime services within the product and chemical tanker market. The company was founded in 2010, originally as BW Tankers Limited before adopting its current name in January 2019.
Operating within the Energy sector under the GICS Oil & Gas Storage & Transportation sub-industry, Hafnia is exposed to global seaborne transportation demand for refined petroleum products, a market influenced by refinery output, trade flows, and IMO emissions regulations that have historically encouraged fleet renewal toward more efficient tonnage. Its inclusion across multiple tanker size classes allows the company to serve both long-haul intercontinental routes and shorter regional voyages.
- Product tanker freight rates rise on tight vessel supply
- Fleet expansion through newbuild orders grows capacity
- IMO environmental regulations scrap older tanker tonnage
| Net Income: 456.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -12.24 > 1.0 |
| NWC/Revenue: 17.73% < 20% (prev 6.26%; Δ 11.47% < -1%) |
| CFO/TA 0.14 > 3% & CFO 579.7m > Net Income 456.3m |
| Net Debt (950.7m) to EBITDA (679.6m): 1.40 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (505.3m) vs 12m ago 0.27% < -2% |
| Gross Margin: 20.65% > 18% (prev 28.46%; Δ -7.81% > 0.5%) |
| Asset Turnover: 62.25% > 50% (prev 71.14%; Δ -8.89% > 0%) |
| Interest Coverage Ratio: 9.76 > 6 (EBIT TTM 479.0m / Interest Expense TTM 49.1m) |
| A: 0.11 (Total Current Assets 1.13b - Total Current Liabilities 708.1m) / Total Assets 4.03b |
| B: 0.22 (Retained Earnings 897.8m / Total Assets 4.03b) |
| C: 0.12 (EBIT TTM 479.0m / Avg Total Assets 3.86b) |
| D: 1.71 (Book Value of Equity 2.54b / Total Liabilities 1.49b) |
| Altman-Z'' = 4.05 = AA |
| DSRI: 1.41 (Receivables 677.1m/526.3m, Revenue 2.41b/2.63b) |
| GMI: 1.38 (GM 28.46% / 20.65%) |
| AQI: 2.54 (AQ_t 0.15 / AQ_t-1 0.06) |
| SGI: 0.91 (Revenue 2.41b / 2.63b) |
| TATA: -0.03 (NI 456.3m - CFO 579.7m) / TA 4.03b) |
| Beneish M = -1.50 (Cap -4..+1) = D |
As of July 07, 2026, the stock is trading at USD 7.11 with a total of 1,065,986 shares traded. Over the past week, the price has changed by +2.01%, over one month by -2.34%, over three months by -8.83% and over the past year by +48.64%.
Current recommended Stop Loss: 6.70 (which is 5.8% or 1.4 ATR below the current price).
Hafnia has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy HAFN.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10 | 40.6% |
P/E Trailing = 7.3778
P/E Forward = 4.7281
P/S = 1.3797
P/B = 1.3058
Revenue TTM = 2.41b USD
EBIT TTM = 479.0m USD
EBITDA TTM = 679.6m USD
Long Term Debt = 734.4m USD (from longTermDebt, last quarter)
Short Term Debt = 246.0m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 71.6m
Net Debt = 950.7m USD (calculated: Debt 1.10b - CCE 146.5m)
Enterprise Value = 4.27b USD (3.32b + Debt 1.10b - CCE 146.5m)
Interest Coverage Ratio = 9.76 (Ebit TTM 479.0m / Interest Expense TTM 49.1m)
EV/FCF = 9.69x (Enterprise Value 4.27b / FCF TTM 440.8m)
FCF Yield = 10.32% (FCF TTM 440.8m / Enterprise Value 4.27b)
FCF Margin = 18.32% (FCF TTM 440.8m / Revenue TTM 2.41b)
Net Margin = 18.97% (Net Income TTM 456.3m / Revenue TTM 2.41b)
Gross Margin = 20.65% ((Revenue TTM 2.41b - Cost of Revenue TTM 1.91b) / Revenue TTM)
Gross Margin QoQ = 23.73% (prev 20.31%)
Tobins Q-Ratio = 1.06 (Enterprise Value 4.27b / Total Assets 4.03b)
Interest Expense / Debt = 4.47% (Interest Expense 49.1m / Debt 1.10b)
Taxrate = 0.41% (1.86m / 458.1m)
NOPAT = 477.1m (EBIT 479.0m * (1 - 0.41%))
Current Ratio = 1.60 (Total Current Assets 1.13b / Total Current Liabilities 708.1m)
Debt / Equity = 0.43 (Debt 1.10b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 1.40 (Net Debt 950.7m / EBITDA 679.6m)
Debt / FCF = 2.16 (Net Debt 950.7m / FCF TTM 440.8m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.81% (Net Income 456.3m / Total Assets 4.03b)
RoE = 19.20% (Net Income TTM 456.3m / Total Stockholder Equity 2.38b)
RoCE = 15.40% (EBIT 479.0m / Capital Employed (Equity 2.38b + L.T.Debt 734.4m))
RoIC = 13.84% (NOPAT 477.1m / Invested Capital 3.45b)
WACC = 6.55% (E(3.32b)/V(4.42b) * Re(7.24%) + D(1.10b)/V(4.42b) * Rd(4.47%) * (1-Tc(0.00)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -15.56 | Cagr: -0.29%
[DCF] Terminal Value 73.10% ; FCFF base≈607.5m ; Y1≈532.7m ; Y5≈430.4m
[DCF] Fair Price = 11.92 (EV 6.91b - Net Debt 950.7m = Equity 5.96b / Shares 499.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -89.24 | EPS CAGR: -33.59% | SUE: 1.92 | # QB: 1
Revenue Correlation: -44.60 | Revenue CAGR: -7.93% | SUE: 0.64 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.18 | Chg30d=+5.88% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.14 | Chg30d=+0.00% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=0.78 | Chg30d=+4.00% | Revisions=+25% | GrowthEPS=+12.6% | GrowthRev=+28.1%
EPS next Year (2027-12-31): EPS=0.64 | Chg30d=+12.28% | Revisions=+25% | GrowthEPS=-17.9% | GrowthRev=-30.6%